While the importance of T-cell immunity in the rejection of the Hepa1-6 cell line was described previously (22), an observation that we confirmed in our model (data not shown), our results clearly demonstrate a role for KC, and therefore the innate immunity component, in tumor rejection. The gene discussed is CALCA; the disease is neoplasm.